Government Owned Invention Available for License: Nucleophosmin 1 (NPM1) Mutation-Specific T Cell…

2026-07-24 · Notice · Federal Register document 2026-14981

Government Owned Invention Available for License: Nucleophosmin 1 (NPM1) Mutation-Specific T Cell Receptors for Targeted Treatment of Acute Myeloid Leukemia (AML)

Health and Human Services Department, National Institutes of Health

Official abstract: The NCI seeks research co-development partners or licensees for NPM1 Mutation-Specific T Cell Receptors for Targeted Treatment of AML.

Read the full document on FederalRegister.gov →Official PDF →